TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · major macro event coming up
INDP

Indaptus Therapeutics Inc

Healthcare · Biotechnology

2.10$ -7.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

Indaptus Therapeutics Inc (INDP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -15 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow INDP
Line item 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-3.8 -3.1 -4.3 -5.4 -4.5 -3.4 -4.8 -7.9 -12 -22 -39 -29 -3.3 -11 -13 -13 -12 -15
0.3 0.3 0.4 0.3 0.6 0.6 0.6 0.7 0.7 0.8 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0
– – – – – – – – – – – 0.1 0.1 1.5 3.0 3.0 2.3 1.4
– – – – – – – – – – – 0.1 0.1 1.5 2.8 – – –
0.2 0.2 -0.8 0.5 -0.5 0.7 0.0 -1.7 0.4 5.1 -0.6 0.2 0.1 -5.1 -1.6 -0.5 0.4 3.5
0.2 0.5 0.5 2.3 0.2 1.5 0.1 1.4 0.5 5.0 9.6 0.9 8.2 0.0 0.2 0.0 0.0 0.0
-0.2 -0.5 -5.2 1.2 -1.5 -3.1 2.7 -6.4 4.7 -4.7 -9.3 -3.2 0.4 0.4 -16 17 – –
– – – – – – – – – – – 0.3 1.2 – – – 0.0 5.7
3.9 4.6 13 3.0 3.4 9.3 4.8 32 – 64 35 2.4 1.2 48 0.4 0.0 4.7 18
– – – – – – – 18 -7.3 37 -14 -30 -2.2 37 -30 3.7 -7.6 2.7
-4.0 -3.6 -4.8 -7.7 -4.7 -4.9 -4.8 -9.3 -12 -27 -49 -30 -3.3 -11 -13 -13 -12 -15

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?